Internal Medicine, Pulmonary Disease · Ocean, NJ
NPI
1619083177
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
301 Bingham Avenue, Suite B
Ocean, NJ, 07712
Phone (732) 575-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$216K
3,333 services
Medicare patients, 2024
1,184
Average age 75
Drug cost, 2024
$3.0M
3,677 prescriptions
Company payments, 2025
$1,920
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rana Y Ali was code 99214 (office e&m - established), 717 times for 438 patients. In total Rana Y Ali billed 3,333 services in 32 codes, and Medicare paid $216K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 717 | 438 | $98.96 | $71K |
| 99232 Hospital E&M - Subsequent | Facility | 448 | 206 | $63.14 | $28K |
| 94010 Pulmonary Function Testing | Office | 406 | 287 | $21.64 | $8,787 |
| G0398 Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Office | 260 | 258 | $38.00 | $9,880 |
| 99222 Hospital E&M - Initial | Facility | 165 | 159 | $104.49 | $17K |
| 99213 Office E&M - Established | Office | 148 | 129 | $65.34 | $9,670 |
| 99233 Hospital E&M - Subsequent | Facility | 120 | 58 | $94.81 | $11K |
| 94729 Pulmonary Function Testing | Office | 119 | 117 | $46.40 | $5,522 |
| 94727 Pulmonary Function Testing | Office | 119 | 117 | $35.57 | $4,233 |
| 94060 Pulmonary Function Testing | Office | 118 | 116 | $30.93 | $3,649 |
| 95810 Sleep Study | Facility | 76 | 74 | $85.38 | $6,489 |
| 95811 Sleep Study | Facility | 59 | 58 | $95.52 | $5,636 |
| 99204 Office E&M - New | Office | 53 | 53 | $124.46 | $6,596 |
| 99291 Critical Care E&M | Facility | 45 | 29 | $169.91 | $7,646 |
| 94375 Pulmonary Function Testing | Office | 31 | 31 | $32.47 | $1,007 |
By year: 2022 $274K for 4,422 services; 2023 $255K for 3,927 services; 2024 $216K for 3,333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rana Y Ali prescribed most often to Medicare patients was Montelukast Sodium, with 423 prescriptions and refills. In total Rana Y Ali wrote 3,677 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 423 | 947 | 108 | $4,859 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 361 | 496 | 153 | $13K |
| Levocetirizine Dihydrochloride Generic | 303 | 588 | 94 | $4,649 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 283 | 421 | 69 | $259K |
| Breo Ellipta Fluticasone/Vilanterol | 217 | 256 | 54 | $100K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 206 | 264 | 37 | $115K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 182 | 239 | 38 | $148K |
| Fluticasone Propionate Generic | 149 | 365 | 83 | $2,973 |
| Spiriva Respimat Tiotropium Bromide | 101 | 145 | 29 | $72K |
| Prednisone Generic | 90 | 98 | 59 | $273 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 83 | 99 | 37 | $17K |
| Symbicort Budesonide/Formoterol Fumarate | 69 | 104 | 28 | $20K |
| Modafinil Generic | 65 | 80 | 14 | $2,974 |
| Famotidine Generic | 63 | 109 | 20 | $533 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 62 | 68 | 12 | $30K |
Brand drugs: 1,907 claims; generic drugs: 1,770 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rana Y Ali $1,920 ($1,920 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $447.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $447 |
| Avadel CNS Pharmaceuticals, LLC | 13 | $277 |
| GlaxoSmithKline, LLC. GSK | 20 | $224 |
| Viatris Specialty LLC | 14 | $170 |
| Harmony Biosciences LLC HRMY | 6 | $115 |
| Genzyme Corporation SNY | 5 | $105 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $97.23 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $79.8 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $76.55 |
| Grifols USA, LLC | 2 | $54.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.